HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy

By R. Heaton, D. Clifford, D. Franklin, S. Woods, C. Ake, Florin Vaida, Ronald J Ellis, S. Letendre, T. Marcotte, J. Atkinson and 16 more. Neurology, 2010

1,661 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/a0b1a65cf7dbceba8973212e3b43643319b555d9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. R. Heaton
2. T. Marcotte
3. Christine Fennema-Notestine
4. D. Franklin
5. Ronald J Ellis
6. S. Woods
7. Terry L. Jernigan
8. J. McCutchan

Citations in the corpus

• HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors (2010, background): “…Therapy Effects Research (CHARTER) cohort (from which our CART era cases were drawn) suggested that the best neurocognitive outcomes may be associated with a combination of successful viral response to CART and absence of historical severe immunosuppression (nadir CD4<200; Heaton et al. 2010).”